Position in NVS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$305,347
-$104,691,732 QoQ
Shares Held
1,999
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PARNASSUS INVESTMENTS, LLC holds $987,357,686 across 3 Drug Manufacturers - General names. NVS ranks #3 (0.0% of the industry book) .
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $305,347 | 1,999 | Shares | Sole | 2026-05-12 | |
| 2022-06-30 | $104,997,079 | 1,242,128 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $108,996,732 | 1,242,128 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $108,648,936 | 1,242,128 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $94,212,113 | 1,152,019 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $85,746,804 | 939,794 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $79,608,293 | 931,309 | Shares | Sole | 2021-05-06 | |
| 2020-03-31 | $23,689,698 | 287,322 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||